C157H170N20O21 — CID 157383470
4-[[4-[(4-tert-butylimidazol-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylpyrrolidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-3-methyl-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one (PubChem CID 157383470) has the molecular formula C157H170N20O21 and a molecular weight of 2673.21 g/mol. Its IUPAC name is 4-[[4-[(4-tert-butylimidazol-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylpyrrolidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-3-methyl-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one.
| Compound Name | 4-[[4-[(4-tert-butylimidazol-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylpyrrolidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-3-methyl-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one |
|---|---|
| PubChem CID | 157383470 |
| Molecular Formula | C157H170N20O21 |
| Molecular Weight | 2673.21 g/mol |
| Exact Mass | 2671.28 |
| IUPAC Name | 4-[[4-[(4-tert-butylimidazol-1-yl)methyl]phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;4-[[4-(1,3-dihydroisoindol-2-ylmethyl)phenyl]methoxy]-2-(6-methylidene-2-oxopiperidin-3-yl)-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(5-methyl-1,3,4-oxadiazol-2-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[(2-methylpyrrolidin-1-yl)methyl]phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one;2-[(3S)-3-methyl-6-methylidene-2-oxopiperidin-3-yl]-4-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3H-isoindol-1-one |
| SMILES | C=C1CCC(N2Cc3c(OCc4ccc(CN5CCCC5C)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5Cc6ccccc6C5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(Cn5cnc(C(C)(C)C)c5)cc4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4nnc(C)o4)cccc3C2=O)C(=O)N1.C=C1CC[C@H](N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1.C=C1CC[C@](C)(N2Cc3c(OCc4ccc(CN5CCOCC5)cc4)cccc3C2=O)C(=O)N1 |
| InChI | InChI=1S/C30H29N3O3.C29H32N4O3.C27H31N3O4.C27H31N3O3.C26H29N3O4.C18H18N4O4/c1-20-9-14-27(29(34)31-20)33-18-26-25(30(33)35)7-4-8-28(26)36-19-22-12-10-21(11-13-22)15-32-16-23-5-2-3-6-24(23)17-32;1-19-8-13-24(27(34)31-19)33-15-23-22(28(33)35)6-5-7-25(23)36-17-21-11-9-20(10-12-21)14-32-16-26(30-18-32)29(2,3)4;1-19-10-11-27(2,26(32)28-19)30-17-23-22(25(30)31)4-3-5-24(23)34-18-21-8-6-20(7-9-21)16-29-12-14-33-15-13-29;1-18-8-13-24(26(31)28-18)30-16-23-22(27(30)32)6-3-7-25(23)33-17-21-11-9-20(10-12-21)15-29-14-4-5-19(29)2;1-18-5-10-23(25(30)27-18)29-16-22-21(26(29)31)3-2-4-24(22)33-17-20-8-6-19(7-9-20)15-28-11-13-32-14-12-28;1-10-6-7-14(17(23)19-10)22-8-13-12(18(22)24)4-3-5-15(13)25-9-16-21-20-11(2)26-16/h2-8,10-13,27H,1,9,14-19H2,(H,31,34);5-7,9-12,16,18,24H,1,8,13-15,17H2,2-4H3,(H,31,34);3-9H,1,10-18H2,2H3,(H,28,32);3,6-7,9-12,19,24H,1,4-5,8,13-17H2,2H3,(H,28,31);2-4,6-9,23H,1,5,10-17H2,(H,27,30);3-5,14H,1,6-9H2,2H3,(H,19,23)/t;;27-;;23-;/m..0.0./s1 |
| InChIKey | BLDRVNNZGWUXRE-LNHKTVHWSA-N |
| XLogP | 20.87 |
| TPSA | 440.00 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 198 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2673.21 |
| LogP ≤ 5 | 20.87 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 29 |